Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 211 - 240 of 254
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Ropivacain Fresenius Kabi 5 mg-ml injektioneste, liuos SPC 2023-08-23
PL	Resepti	Ropivacaine BioQ 2 mg/ml infuusioneste, liuos, antovälineistö, SPC 2024-01-29
PL	Resepti	Rosamera 10mg-5mg-4mg, 10mg-5mg-8mg, 10mg-10mg-8mg, 20mg-5mg-4mg, 20mg-5mg-8mg, 20mg-10mg-8mg tabletti, kalvopäällysteinen SPC 2023-06-26
PL	Resepti/itsehoito	Rosazol 1 % emulsiovoide SPC 2019-10-09
PL	Resepti	Rosuvastatin Actavis 15 mg, 30 mg tabletti, kalvopäällysteinen SPC 2023-05-23
PL	Resepti	Rosuvastatin Actavis 5 mg, 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2023-09-27
PL	Resepti	Rosuvastatin Krka 15 mg, 30 mg tabletti, kalvopäällysteinen SPC 2023-03-15
PL	Resepti	Rosuvastatin Krka 5 mg, 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2023-03-15
PL	Resepti	Rosuvastatin Orion 5 mg, 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2024-11-05
PL	Resepti	Rosuvastatin ratiopharm 5 mg, 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2023-03-15
PL	Resepti	Rosuvastatin Sandoz 5 mg, 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2023-03-20
PL	Resepti	Rosuvastatin Stada 5 mg, 10 mg, 20 mg, 40 mg, tabletti, kalvopäällysteinen SPC 2024-02-26
PL	Resepti	Rosuvastatin Xiromed 5 mg, 10 mg, 20 mg, 40 mg tabletti, kalvopäällysteinen SPC 2023-02-28
PL	Resepti	Rosuvastatin-Ezetimib Krka 5 mg-10 mg, 10 mg-10 mg, 20 mg-10 mg tabletti, kalvopäällysteinen SPC 2023-11-15
PL	Resepti	Rosuvastatin-Ezetimibe ratiopharm 5 mg - 10 mg, 10 mg - 10 mg tabletti SPC 2024-07-31
		European Medicines Agency's website: Rotarix - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: RotaTeq - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Roteas - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Roteas - EMA: EPAR PI Finnish Swedish
PL	Resepti	Rotigotine Medical Valley 1 mg-24 tuntia, 3 mg-24 tuntia depotlaastari SPC 2024-09-11
PL	Resepti	Rotigotine Medical Valley 2 mg-24 tuntia depotlaastari SPC 2024-09-11
PL	Resepti	Rotigotine Medical Valley 4 mg-24 tuntia, 6 mg-24 tuntia, 8 mg-24 tuntia depotlaastari SPC 2024-09-11
PL	Resepti	ROTOP-NanoHSA 0.5 mg valmisteyhdistelmä radioaktiivista lääkettä varten SPC 2022-09-30
PL	Itsehoito	Rowiren emulsiovoide SPC 2021-07-20
PL	Resepti	Roxiper 10 mg-4 mg-1.25 mg, 20 mg-4 mg-1.25 mg, 10 mg-8 mg-2.5 mg, 20 mg-8 mg-2.5 mg tabletti, kalvopäällysteinen SPC 2023-05-23
PL	Resepti	Roxithromycin Orifarm 150 mg, 300 mg tabletti, kalvopäällysteinen SPC 2022-01-03
PL	Resepti	Roxithromycin Sandoz 150 mg, 300 mg tabletti, kalvopäällysteinen SPC 2021-06-18
PL	Resepti/itsehoito	Rozex 0.75 prosenttinen emulsiovoide SPC 2021-09-06
PL	Resepti/itsehoito	Rozex 0.75 prosenttinen geeli SPC 2021-07-09
		European Medicines Agency's website: Rozlytrek - EMA: EPAR PI Finnish Swedish
<  Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >